Pharma Journalist - Page 725 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Alveo Technologies Curates economically viable disease diagnostic devices

SSSB and F1 oncology foray into Development, Manufacturing and Supply agreements

Takeda and Denali Therapeutics Ventures to combat Neurodegenerative diseases

Celgene and Impact Biomedicines accede to collaborate

Leading Pharma acquires growth capital of $40 million

Semnur Initiates Phase 3 Clinical Trial to assess its SP-102 in lumbar radicular pain/sciatica afflicted patients

Jiangsu Hengrui Medicine Partners with Arcutis to Develop Hengrui’s SHR0302 Drug for treating dermatology disorders

9 Reasons to Attend the Paediatric Clinical Trials 2018 Conference